5P1.F Prim S.A
- Market cap
- EUR 208M
- P/E
- 15.9x
- P/B
- 1.51x
- ROE
- 12.1%
- Dividend yield
- 3.84%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 5P1.F undervalued?
Graham number5P1.F trades 3.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Prim S.A fundamental analysis
No fundamental analysis for Prim S.A yet.
Prim S.A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Prim S.A
Prim, S.A. operates as a health technology, mobility, and health care products provider in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic protectors under the airtex PRO, bruxi calm, fisionprim, newfeet, ORTHOPrim, PRIM,…
Full company profilePrim S.A financial statements
Prim S.A annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 110M | 121M | 134M | 151M | 147M | 169M | 197M | 217M | 233M | 252M |
| Gross Profit | 58.4M | 64.0M | 71.8M | 77.6M | 74.5M | 83.1M | 94.6M | 107M | 111M | 129M |
| Operating Income | 13.3M | 15.2M | 16.8M | 15.2M | 14.5M | 17.2M | 11.6M | 15.9M | 14.3M | 25.7M |
| EBITDA | - | 20.8M | 21.6M | 22.1M | 15.3M | 30.1M | 19.5M | 27.9M | 26.2M | 33.9M |
| Net Income | 13.1M | 13.9M | 14.1M | 11.2M | 6.92M | 17.4M | 8.39M | 12.7M | 10.9M | 16.7M |
| EPS | - | 0.80 | 0.81 | 0.65 | 0.40 | 1.02 | 0.49 | 0.74 | 0.64 | 0.98 |
| Balance Sheet | ||||||||||
| Total Assets | 128M | 138M | 138M | 150M | 164M | 180M | 185M | 200M | 190M | 197M |
| Total Liabilities | 27.4M | 31.7M | 29.5M | 38.6M | 51.9M | 58.4M | 65.3M | 74.3M | 61.3M | 58.9M |
| Shareholders' Equity | 101M | 106M | 109M | 111M | 112M | 121M | 120M | 126M | 129M | 138M |
| Cash & Short-term Investments | 6.22M | 15.7M | 8.81M | 5.52M | 31.8M | 32.3M | 10.9M | 6.44M | 9.63M | 18.3M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 10.3M | 10.9M | 6.57M | -616K | 25.0M | 24.5M | 4.89M | - | - | - |
| Capital Expenditure | 3.13M | 2.11M | 4.08M | 5.32M | 5.47M | 11.6M | 11.8M | 10.4M | 11.3M | 12.3M |
| Free Cash Flow | - | 7.84M | 500K | -6.64M | 18.6M | 12.1M | -7.02M | -21.7M | 10.8M | 18.1M |
| Ratios | ||||||||||
| ROE | 13.0% | 13.1% | 13.0% | 10.1% | 6.2% | 14.3% | 7.0% | 10.1% | 8.5% | 12.1% |
| ROA | 10.2% | 10.1% | 10.2% | 7.5% | 4.2% | 9.7% | 4.5% | 6.3% | 5.7% | 8.5% |
| Net Profit Margin | 11.9% | 11.5% | 10.5% | 7.4% | 4.7% | 10.3% | 4.3% | 5.9% | 4.7% | 6.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Prim S.A dividends
- Dividend yield
- 3.84%
- Forward dividend
- 0.53 EUR
- Payout ratio
- 47.9%
- Ex-dividend date
- Jul 13, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 7.98M | 0.47 | 47.9% |
| 2024 | EUR 7.60M | 0.45 | 69.6% |
| 2023 | EUR 6.24M | 0.37 | 49.2% |
| 2022 | EUR 8.84M | 0.52 | 105.3% |
| 2021 | EUR 5.40M | 0.32 | 31.0% |
| 2020 | EUR 7.63M | 0.44 | 110.3% |
| 2019 | EUR 10.0M | 0.58 | 89.4% |
| 2018 | EUR 10.0M | 0.58 | 70.9% |
| 2017 | EUR 7.98M | 0.46 | 57.4% |
| 2016 | EUR 6.39M | - | 48.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Feb 20, 2006.
Who owns Prim S.A
- Insiders 59.76%
- Institutions 12.28%
- Public & others 27.96%
- Shares outstanding 17.0M
- Free float 16.0M
Prim S.A company profile
- Company name
- Prim S.A
- Ticker
- 5P1.F
- ISIN
- ES0170884417
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 958
- Fiscal year end
- December
- Address
- Polígono Industrial número 1, Móstoles, Spain, 28938
- Phone
- 34 91 334 24 00
- Website
- prim.es
About Prim S.A
Prim, S.A. operates as a health technology, mobility, and health care products provider in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic protectors under the airtex PRO, bruxi calm, fisionprim, newfeet, ORTHOPrim, PRIM, PRIMcare, respira PLUS, airMed, airtex, aqtivo skin, aqtivo sport, comforGel, comforGel Lady, comforSil, ESSENCIAL, mottio sport range, my PRIM Kids, Neoprair, ONE SIZE, Primespine, and OLIUM brand names. It operates PrimAcademy, an offline and digital training platform. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.
Prim S.A management
4- Mr. Pedro PrimFounder
- Mr. Ignacio Prim MartinezExecutive Director
- Mr. Fernando Oliveros ArreagaExecutive Director
- Mr. Rafael Alonso DregiSecretary